Pneuma Systems Corporation
Pneuma Systems Corporation specializes in designing and licensing closed-loop fluid control systems that precisely manage small fluid volumes without the complexity of traditional pumping mechanisms. The company leverages over 30 inventions and three novel subsystems to revolutionize fluid flow, workflow, information flow, and cash flow, aiming to transform the standard of care in infusion therapy. Pneuma is a small team of experienced medical device professionals working on a new technology platform for precise fluid delivery, with an emphasis on infusion therapy. Armed with a strong IP portfolio, Pneuma’s infusion controller is designed to support all venues of infusion therapy including acute care, standalone infusion centers, and home care. The design offers significant advances in fluid flow, information flow, and work flow. The design has been accepted into an accelerated review program by the U.S. Food and Drug Administration (FDA), known as STeP.
Industries
Nr. of Employees
small (1-50)
Pneuma Systems Corporation
111 Bow Street, Suite 6, Portsmouth, NH 03801
Pneuma Systems Corporation is currently seeking investment
Pneuma Systems Corporation is seeking a series-b investment in the range of 1m-5m
Products
Infusion controller and administration set platform (in development)
Integrated controller and administration sets intended to provide closed-loop control of intravenous fluid delivery and to maintain therapy continuity across care settings.
Administration sets and container interfaces (collaboration)
Administration sets and delivery-system interfaces developed in collaboration with medication container and delivery-system suppliers to improve patient experience and device compatibility.
Infusion controller and administration set platform (in development)
Integrated controller and administration sets intended to provide closed-loop control of intravenous fluid delivery and to maintain therapy continuity across care settings.
Administration sets and container interfaces (collaboration)
Administration sets and delivery-system interfaces developed in collaboration with medication container and delivery-system suppliers to improve patient experience and device compatibility.
Expertise Areas
- Closed-loop infusion device development
- Infusion therapy workflow optimization
- Reliability engineering and device diagnostics
- Regulatory strategy for medical devices (including accelerated pathways)
Key Technologies
- Closed-loop flow control
- Microfluidic/low-flow delivery methods
- Embedded device software and firmware
- Device self-diagnostics and failure-mode detection
Key People
News & Updates
ECRI's list identifies potential sources of danger in health technology, with a focus on infusion pumps, and offers recommendations for reducing risks.
The 9th Edition calls for standardizing pump types within organizations to promote user familiarity and minimize re-establishing infusions after patient transfers.
Pneuma Systems Corporation's infusion system has been added to the FDA's Safer Technologies Program (STeP), which accelerates regulatory review for medical devices offering significant advantages over current options.
ECRI's list identifies potential sources of danger in health technology, with a focus on infusion pumps, and offers recommendations for reducing risks.
The 9th Edition calls for standardizing pump types within organizations to promote user familiarity and minimize re-establishing infusions after patient transfers.
Pneuma Systems Corporation's infusion system has been added to the FDA's Safer Technologies Program (STeP), which accelerates regulatory review for medical devices offering significant advantages over current options.